Drug Discovery & Development
<img alt="" height="1" width="1" />
Gene analysis fails to help predict best warfarin dose
Reuters
(Reuters) - Gene analysis failed in a U.S. clinical trial to help doctors select better doses of warfarin, the widely used blood-thinner, which can cause dangerous bleeding if doses are too high and fail to protect against blood clots and strokes if doses are too ...
Role of genetics in warfarin dosing a source of debateHealio
Genetic Data Does Not Improve Warfarin DosingDrug Discovery & Development
New study finds no benefit to selecting dose of blood thinner based on patients ...Medical Xpress
all 14 news articles »
More...